ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Gynaecological Malignancies
Gynaecological Tumours
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
OUTBACK Trial: No Cervical Cancer Survival Gain With Adjuvant Chemotherapy
‘Disappointing’ Mortality Outcomes Shown For Ovarian Cancer Screening Trial
Carboplatin–Paclitaxel Recommended For Elderly Advanced Ovarian Cancer Patients
SOLO2 Final Analysis Demonstrates ‘Unprecedented’ OS Boost
New Standard Regimen Proposed For Recurrent Ovarian Cancer
E-Learning
ESMO E-Learning: HPV-Related Cancers: Prevention, Vaccines and Treatment
ESMO E-Learning: Ovarian Cancer IP Chemotherapy
ESMO E-Learning: Management of BRCA Mutated Ovarian Cancer
Factsheets on Biomarkers
Microsatellite Instability - Defective DNA Mismatch Repair: ESMO Biomarker Factsheet
BRCA1 and BRCA2 in Ovarian Cancer: ESMO Biomarker Factsheet
Meeting resources
ESMO Congress
ESMO Gynaecological Cancers Virtual Congress 2021
Current and emerging biomarkers in recurrent OvCa
Presenter: Susana Banerjee
Session: Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next?
Resources:
Slides
Webcast
Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation
Presenter: Andres Maria Poveda Velasco
Session: Best of abstracts session
Resources:
Slides
Webcast
Discussion
Presenter: Susana Banerjee
Session: Best of abstracts session
Resources:
Slides
Webcast
Global experience using PARP inhibitors in treatment of ovarian cancer
Presenter: Jonathan Ledermann
Session: AstraZeneca - Key questions on PARP inhibitors in ovarian cancer: Experts evaluate the latest evidence
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.